Disrupting the NAD+/NAM metabolic ratio driven by IL-1β inflammatory response potentiates chemotherapy and…

Real-world effectiveness of first-line chemoimmunotherapy versus chemotherapy in older adults with extensive-stage small cell lung cancer: an inverse probability treatment weighted analysis
Siyuan Cui, Kui Zhao, Na Wang +4
Future Oncology20 Oct 2026Peer-reviewedLicence not statedFull textOncologyPMC
Preoperative metabolic–inflammatory profiles and early postoperative recovery after immediate breast reconstruction in patients with and without neoadjuvant chemotherapy: a retrospective cohort study
Fan Wang, Lan Yang, Wei Bai +4
Frontiers in Endocrinology26 Oct 2026Peer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefDOAJ
Efficacy comparison of neoadjuvant chemotherapy, chemoradiotherapy, and chemoimmunotherapy in resectable esophageal squamous cell carcinoma: short- and long-term outcomes from a propensity score-matched analysis
Hai Zhang, Yujing Liang, Chaolin Li +3
Frontiers in medicine19 Oct 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
Astragali Radix-Curcumae Rhizoma synergistically potentiates 5-fluorouracil antitumor efficacy in colorectal cancer by disrupting DNA repair-cell cycle coordination.
Shasha Wang, Kexuan Huang, Yuhan Cheng +7
Chinese medicine21 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Induction Chemoimmunotherapy Versus Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Study
Jiayue Liu, Wei Deng, Xin Dong +11
Journal of Clinical Medicine19 Oct 2026Peer-reviewedCC BY 4.0Surgery & anaesthesiaCrossref

Cite

BibTeX

@article{xing2026disrupting,
  title = {{Disrupting the NAD+/NAM metabolic ratio driven by IL-1β inflammatory response potentiates chemotherapy and chemoimmunotherapy in mice}},
  author = {Fuxue Xing and Hongwei Lv and Liang Wang and Yun Feng and Wei Xiang and Lu Wu and Guoqing Jiang and Yue Ma and Xiaoyan Sun and Zixin Wu and Kunqing Xiao and Qiuyu Lu and Min Zhang and Qianni Zong and Guishuai Lv and Chunying Liu and Qiyu Feng and Hongyang Wang and Wen Yang},
  journal = {Nature Communications},
  year = {2026},
  month = oct,
  doi = {10.1038/s41467-026-78491-z},
  url = {https://www.nature.com/articles/s41467-026-78491-z},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Disrupting the NAD+/NAM metabolic ratio driven by IL-1β inflammatory response potentiates chemotherapy and chemoimmunotherapy in mice
AU  - Fuxue Xing
AU  - Hongwei Lv
AU  - Liang Wang
AU  - Yun Feng
AU  - Wei Xiang
AU  - Lu Wu
AU  - Guoqing Jiang
AU  - Yue Ma
AU  - Xiaoyan Sun
AU  - Zixin Wu
AU  - Kunqing Xiao
AU  - Qiuyu Lu
AU  - Min Zhang
AU  - Qianni Zong
AU  - Guishuai Lv
AU  - Chunying Liu
AU  - Qiyu Feng
AU  - Hongyang Wang
AU  - Wen Yang
PY  - 2026
DA  - 2026/10/13
JO  - Nature Communications
DO  - 10.1038/s41467-026-78491-z
UR  - https://www.nature.com/articles/s41467-026-78491-z
SN  - 2041-1723
ER  -

Related

Cite